Stay updated with breaking news from Equinox Science. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
– Positive masked safety data update for EYP-1901 in ongoing PAVIA and DAVIO 2 Phase 2 clinical trials as of October 1, 2023 with no drug related ...
Investor Presentation October 2023 Forward-Looking Statements Various statements made in this presentation...
– Stuart Duty appointed to EyePoint's Board of Directors – – George Elston promoted to Executive Vice President – WATERTOWN, Mass., Oct. 16, 2023 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc.
Investor Presentation September 2023 Forward-Looking Statements Various statements made in this presentation...
Investor Presentation July 2023 Forward-Looking Statements Various statements made in this presentation are...